| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 05/10/2002 | WO2002022600A3 Chemokine receptor binding heterocyclic compounds |
| 05/10/2002 | WO2002008200A3 Arylethene-sulfonamides, their preparation and their use as endothelin antagonists |
| 05/10/2002 | WO2001081342A3 Novel epothilone derivatives, method for the preparation thereof and their pharmaceutical use |
| 05/10/2002 | WO2001064650A3 Synthesis of epothilones, intermediates thereto and analogues thereof |
| 05/10/2002 | WO2001038324A3 Imidazole derivatives and their use as raf kinase inhibitors |
| 05/10/2002 | WO2001024827A3 INHIBITORS OF THE ENDOTHELIN SIGNALLING PATHWAY AND αVβ3 INTEGRIN RECEPTOR ANTAGONISTS FOR COMBINATION THERAPY |
| 05/10/2002 | WO2000075237A9 pH SENSITIVE CYANINE DYES AS REACTIVE FLUORESCENT REAGENTS |
| 05/09/2002 | US20020055640 Process for the production of dithiazolyl disulfides |
| 05/09/2002 | US20020055631 N-acylsulfonamide apoptosis promoters |
| 05/09/2002 | US20020055522 Treatment of thrombotic diseases, asthma, emphysema, cirrhosis, arthritis, carcinoma, melanoma, restenois, atheroma, trauma, shock and reperfusion injury. |
| 05/09/2002 | US20020055519 2-cyclohexyl imidazopyridine NMDA/NR2B antagonists |
| 05/09/2002 | US20020055508 Benzofurazan compounds which enhance AMPA receptor activity |
| 05/09/2002 | US20020055505 Sultam and sultone derived oxazolidinones |
| 05/09/2002 | US20020055181 Light generating compound for use in the detection of preferential particles in sample |
| 05/08/2002 | EP1203770A1 Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating hyperplasia and other diseases |
| 05/08/2002 | EP1203769A1 Hypolipidemic 1,4-benzothiazepine derivative |
| 05/08/2002 | EP1203766A2 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
| 05/08/2002 | EP1202991A1 Pharmaceutical compositions containing thiazolidinedione derivatives and process for their preparation |
| 05/08/2002 | EP1202990A2 Neurotrophic pyrrolidines and piperidines, and related compositions containing them |
| 05/08/2002 | EP1202988A2 Novel integrin receptor antagonists |
| 05/08/2002 | EP1202985A2 Chemokine receptor antagonists |
| 05/08/2002 | EP1202984A1 Novel diphenyl-piperidine derivate |
| 05/08/2002 | EP1202980A1 2-arylimino-2,3-dihydrothiazoles, and their use thereof as somatostatin receptor ligands |
| 05/08/2002 | EP1202976A1 Pyrazinones, compositions containing such compounds |
| 05/08/2002 | EP1202975A1 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade |
| 05/08/2002 | EP1202968A2 Antibacterial agents |
| 05/08/2002 | EP1202966A1 Piperidine alcohols |
| 05/08/2002 | EP1202733A1 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 05/08/2002 | EP1202626A1 Alpha-hydroxy-gamma-[[(carbocyclic-or heterocyclic-substituted)amino]carbonyl]alkanamide derivatives and uses thereof |
| 05/08/2002 | CN1348449A Heteroaryl diazacycloalkanes, their preparation and use |
| 05/08/2002 | CN1348446A Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing phenylenediamine group |
| 05/08/2002 | CN1348441A N-substituted arylsulfonyl-lamino hydroxamic acids |
| 05/08/2002 | CN1348370A Cyclic protein tyrosine kinase inhibitors |
| 05/08/2002 | CN1347884A Vinyl-pyrrolidone cynnematin with alkali subtituent |
| 05/08/2002 | CN1347883A Vinyl-pyrrolidone cynnematin with alkali subtituent |
| 05/08/2002 | CN1347882A Vinyl-pyrrolidone cynnematin with alkali subtituent |
| 05/08/2002 | CN1347881A 法呢基蛋白转移酶抑制剂 Farnesyl protein transferase inhibitor |
| 05/08/2002 | CN1347875A Novel cyclobutene diketone compound and its producing process, and pharmaceutical composition containing the same compound |
| 05/08/2002 | CA2361226A1 Process for the production of dithiazolyl disulfides |
| 05/07/2002 | US6384235 Preparation of substituted indoles |
| 05/07/2002 | US6384230 2,6-dimethyl-5-((4-ethoxyphenyl)-methoxy)-7-(2-methylthiazol-4-yl)hepta -2,6-dienoic acid ethyl ester from malic acid, wittig reaction with 2-methyl-4-thiazolylmethyl triphenyl phosphonium bromide; intermediates for epothilone a or b |
| 05/07/2002 | US6384220 Antidiabetic agents increasing the expression of glucokinase (gk) to improve glucose tolerance; increase in glucose exposure coupled through gk in beta-cells to increase insulin secretion and in hepatocytes to increase glycogen deposition |
| 05/07/2002 | US6384065 Spiro compounds or salts thereof and preventives/remedies for autoimmune diseases and AP-1 inhibitors containing the same |
| 05/07/2002 | US6384061 Hydantoin compounds and methods related thereto |
| 05/07/2002 | US6384056 Cognition activators and nerve and vision disorders |
| 05/07/2002 | US6384052 Anticoccidial compounds |
| 05/07/2002 | US6384036 Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors |
| 05/07/2002 | US6384035 Heterocycles useful in the treatment of benign prostatic hyperplasia |
| 05/07/2002 | US6384032 Inhibitors of IL-12 production |
| 05/07/2002 | US6384030 Water soluble azoles as broad-spectrum antifungals |
| 05/07/2002 | US6383986 Use as herbicides, desiccants or defoliants and plant safening agents |
| 05/07/2002 | US6383666 Organometallic complex and organic electroluminescent device using the same |
| 05/07/2002 | CA2098612C Arthropodicidal carboxanilides |
| 05/02/2002 | WO2002034745A1 Chemokine receptor binding heterocyclic compounds |
| 05/02/2002 | WO2002034744A1 Quinazoline derivatives |
| 05/02/2002 | WO2002034734A1 Process for the manufacture of thiazole derivatives with pesticidal activity |
| 05/02/2002 | WO2002034726A2 Pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 05/02/2002 | WO2002034718A1 Amide derivatives as nmda receptor antagonists |
| 05/02/2002 | WO2002014323A3 Polymorphs of an epothilone analog |
| 05/02/2002 | WO2001070733A3 Di-substituted iminoheterocyclic compounds |
| 05/02/2002 | WO2001024828A3 MODULATORS OF CYTOKINE MEDIATED SIGNALLING PATHWAYS AND INTEGRIN αVβ3 RECEPTOR ANTAGONISTS FOR COMBINATION THERAPY |
| 05/02/2002 | WO2001023375A3 Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
| 05/02/2002 | WO2001009121A3 2-pyrazolin-5-ones_as tyrosine kinase inhibitors |
| 05/02/2002 | US20020052514 1-(phenylmethyl)sulfonyl-2-hydroxymethyl pyrrolidine for example; use treating neurological disorders including physically damaged nerves and neurodegenerative diseases; treating alopecia and promoting hair growth |
| 05/02/2002 | US20020052513 Oxamide IMPDH inhibitors |
| 05/02/2002 | US20020052510 N-linked sulfonamides of n-heterocyclic carboxylic acids or carboxylic acid isosteres |
| 05/02/2002 | US20020052503 Substituted benzolactam compounds as substance p antagonists |
| 05/02/2002 | US20020052495 Pyramidine or triazine derivatives which specifically inhibit the binding of endothelin to the receptor |
| 05/02/2002 | US20020052482 Covalently linked oligonucleotide minor grove binder conjugates |
| 05/02/2002 | US20020052470 Alpha amino acid derivatives--inhibitors of leukocyte adhesion mediated by VLA-4 |
| 05/02/2002 | US20020052410 Administering to the animal suffering from neurological disorders an amide compound having an affinity for FKBP-type immunophilins |
| 05/02/2002 | US20020052403 Taxane formulations |
| 05/02/2002 | US20020052399 In particular as inhibitors of HIV protease. |
| 05/02/2002 | US20020052398 Pharmaceutical composition of 6-amino EM-12 |
| 05/02/2002 | US20020052396 Caused by viruses of the Flaviviridae family; administering certain rhodanine derivatives, and analogs thereof, tri- and tetracyclic rhodanine alkanoic acids and rhodanine benzoic acids being particularly effective. |
| 05/02/2002 | US20020052393 Benzanilides as potassium channel openers |
| 05/02/2002 | US20020052392 Have utility as, inter alia, hypoglycemic, and anti-obesity agents. |
| 05/02/2002 | US20020052386 Pyrimidine derivatives |
| 05/02/2002 | US20020052378 Novel compounds and compositions as protease inhibitors |
| 05/02/2002 | US20020052376 Imidazole derivatives and their use as farnesyl protein transferase inhibitors |
| 05/02/2002 | US20020052375 3-(Heteroaryal) alanine derivatives-inhibitors of leukocyte adhesion mediated by VLA-4 |
| 05/02/2002 | US20020052358 Methods and compositions related to modulators of annexin and cartilage homeostasis |
| 05/02/2002 | US20020052028 Bio-intermediates for use in the chemical synthesis of polyketides |
| 05/02/2002 | US20020050563 Process for the preparation of pharmaceutically active thiazolidine or oxazolidine compounds by a yeast reductase |
| 05/02/2002 | EP1201661A1 Heteroaromatic ring compounds |
| 05/02/2002 | EP1201650A2 Ionic malonitril derivatives and their uses |
| 05/02/2002 | EP1200429A1 1-cycloalkylpyrazoyl-benzoyl derivatives |
| 05/02/2002 | EP1200422A2 Pyrazole compositions useful as inhibitors of erk |
| 05/02/2002 | EP1200419A1 Aminothiazole derivatives and their use as crf receptor ligands |
| 05/02/2002 | EP1200416A1 Oxazolidinones and their use as antiinfectives |
| 05/02/2002 | EP1200086A2 Methods for treating or preventing pain and anxiety |
| 05/02/2002 | EP1146875A4 Myt1 kinase inhibitors |
| 05/02/2002 | CA2425280A1 Pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 05/02/2002 | CA2421796A1 Chemokine receptor binding heterocyclic compounds |
| 05/01/2002 | CN1347414A Triazole compounds with dopamine-D3-receptor affinity |
| 05/01/2002 | CN1347412A O-aryl dithiazole dioxides |
| 05/01/2002 | CN1347318A Inhibitors of IMPDH enzyme |
| 05/01/2002 | CN1346826A Microbicidal halobenzoimidazole, composition and process for preparing same |
| 05/01/2002 | CN1083839C Novel compound and use thereof |
| 05/01/2002 | CN1083715C Use of insulin sensitisers for treating renal diseases |